Click here to read the Cover Story, “Lifetime vision plans tailored to treat patients’ personal and future needs.”Glaucoma patients deserve the best level of care, and this includes any new technologies that allow them to improve vision. However, it is…
Scientists 3D Print Vascularized Artificial Skin
Researchers from Rensselaer Polytechnic Institute have developed a new method to 3D print living skin with built-in blood vessels. This living skin construct is cultured in vitro and develops into an interconnected microvascular network underneath a layered barrier of skin cells. in tests on mice, the grafts connect with the animals’ vascular (Read more...)
Scientists 3D Print Vascularized Artificial Skin
Researchers from Rensselaer Polytechnic Institute have developed a new method to 3D print living skin with built-in blood vessels. This living skin construct is cultured in vitro and develops into an interconnected microvascular network underneath a layered barrier of skin cells. in tests on mice, the grafts connect with the animals’ vascular (Read more...)
VIDEO: Private equity affects how technology is acquired
NEWPORT BEACH, Calif. — At the OCTANe Medical Technology Innovation Forum, Jim Mazzo, global president of ophthalmic devices at Carl Zeiss Meditec, discusses the impact private equity is having on how equipment and technology are purchased for medical …
Clinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presented During ACR Annual Meeting
DUBLIN–(BUSINESS WIRE)–Horizon announced that clinical data for teprotumumab in the treatment of active thyroid eye disease will be presented at the ACR Annual Meeting.
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its FDA-approved ophthalmic drug OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1%/0.3% reduces use of…